Table 2.

Lymphocyte phenotypes in peripheral blood mononuclear cells of dogs with visceral leishmaniasis subjected to immunotherapy with Leishmune^®

Treatment	Dog	CD4%	CD8%	CD21%
Leishmune®	1	38.81	32.52	4.59
	2	55.65	31.26	18.85
	3	32.78	21.10	11.69
	4	50.13	19.16	18.54
	5	20.35	53.79	17.37
	6	33.10	22.28	13.42
	7	48.61	23.59	17.25
	8	23.29	52.99	9.70
	9	40.13	17.42	4.01
	10	35.68	56.24	3.45
	11	54.86	19.24	4.27
	12	40.03	16.61	9.46
	13	85.37	12.63	9.81
	14	80.47	12.19	3.06
	15	29.83	9.28	12.51
	Average	44.61	26.69	10.53
	IC95%	34.79–54.41	18.48–34.87	7.52–13.54
Normal	1	36.09	20.85	4.35
	2	43.59	25.90	5.58
	3	37.07	16.08	6.37
	4	47.94	17.10	3.33
	5	35.17	16.48	9.43
	6	23.68	24.75	0
	7	41.71	33.46	5.46
	8	36.07	25.44	0.44
	9	35.38	14.89	4.6
	Average	44.07	19.45	6.07
	IC95%	21.40–51.28	11.27–22.50	3.01–7.98

Data of Leishmune^®-vaccinated dogs of Araçatuba and Andradina, 2 years after vaccination and of healthy normal dogs.